Daveen Chopra - 15 Nov 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Surgical Structural Heart
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 15 Nov 2022
Net transactions value: -$115,613
Form type: 4
Filing time: 15 Nov 2022, 15:47:28 UTC
Previous filing: 14 Oct 2022
Next filing: 15 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$181,107	+4,000	+21%	$45.28	22,911	15 Nov 2022	Direct	F1
transaction	EW	Common Stock	Sale	$296,720	-4,000	-17%	$74.18	18,911	15 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Employee Stock Option (Right to Acquire)	Options Exercise	$0	-4,000	-20%	$0.000000	16,435	15 Nov 2022	Common Stock	4,000	$45.28	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.